STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $21.58 billion. The enterprise value is $24.76 billion.
| Market Cap | 21.58B |
| Enterprise Value | 24.76B |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, after market close.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | Jun 12, 2024 |
Share Statistics
STERIS has 98.85 million shares outstanding. The number of shares has decreased by -0.47% in one year.
| Shares Outstanding | 98.85M |
| Shares Change (YoY) | -0.47% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 98.94% |
| Float | 98.53M |
Valuation Ratios
The trailing PE ratio is 57.31 and the forward PE ratio is 23.49. STERIS's PEG ratio is 6.88.
| PE Ratio | 57.31 |
| Forward PE | 23.49 |
| PS Ratio | 4.20 |
| Forward PS | 3.86 |
| PB Ratio | 3.42 |
| P/FCF Ratio | 34.79 |
| PEG Ratio | 6.88 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.01, with an EV/FCF ratio of 39.91.
| EV / Earnings | 65.46 |
| EV / Sales | 4.82 |
| EV / EBITDA | 20.01 |
| EV / EBIT | 36.84 |
| EV / FCF | 39.91 |
Financial Position
The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.54.
| Current Ratio | 3.08 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 2.73 |
| Debt / FCF | 5.45 |
| Interest Coverage | 4.66 |
Financial Efficiency
Return on equity (ROE) is 6.00% and return on invested capital (ROIC) is 6.19%.
| Return on Equity (ROE) | 6.00% |
| Return on Assets (ROA) | 3.40% |
| Return on Capital (ROIC) | 6.19% |
| Revenue Per Employee | $282,672 |
| Profits Per Employee | $20,806 |
| Employee Count | 18,179 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 4.57 |
Taxes
In the past 12 months, STERIS has paid $149.53 million in taxes.
| Income Tax | 149.53M |
| Effective Tax Rate | 28.33% |
Stock Price Statistics
The stock price has decreased by -0.37% in the last 52 weeks. The beta is 0.85, so STERIS's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -0.37% |
| 50-Day Moving Average | 219.90 |
| 200-Day Moving Average | 218.35 |
| Relative Strength Index (RSI) | 45.53 |
| Average Volume (20 Days) | 509,062 |
Short Selling Information
The latest short interest is 3.08 million, so 3.11% of the outstanding shares have been sold short.
| Short Interest | 3.08M |
| Short Previous Month | 2.61M |
| Short % of Shares Out | 3.11% |
| Short % of Float | 3.12% |
| Short Ratio (days to cover) | 6.02 |
Income Statement
In the last 12 months, STERIS had revenue of $5.14 billion and earned $378.24 million in profits. Earnings per share was $3.81.
| Revenue | 5.14B |
| Gross Profit | 2.22B |
| Operating Income | 836.12M |
| Pretax Income | 527.77M |
| Net Income | 378.24M |
| EBITDA | 1.24B |
| EBIT | 672.12M |
| Earnings Per Share (EPS) | $3.81 |
Balance Sheet
The company has $207.02 million in cash and $3.38 billion in debt, giving a net cash position of -$3.18 billion or -$32.13 per share.
| Cash & Cash Equivalents | 207.02M |
| Total Debt | 3.38B |
| Net Cash | -3.18B |
| Net Cash Per Share | -$32.13 |
| Equity (Book Value) | 6.30B |
| Book Value Per Share | 63.75 |
| Working Capital | 1.94B |
Cash Flow
In the last 12 months, operating cash flow was $973.27 million and capital expenditures -$352.95 million, giving a free cash flow of $620.33 million.
| Operating Cash Flow | 973.27M |
| Capital Expenditures | -352.95M |
| Free Cash Flow | 620.33M |
| FCF Per Share | $6.28 |
Margins
Gross margin is 43.17%, with operating and profit margins of 16.27% and 7.36%.
| Gross Margin | 43.17% |
| Operating Margin | 16.27% |
| Pretax Margin | 10.27% |
| Profit Margin | 7.36% |
| EBITDA Margin | 24.08% |
| EBIT Margin | 13.08% |
| FCF Margin | 12.07% |
Dividends & Yields
This stock pays an annual dividend of $2.08, which amounts to a dividend yield of 0.95%.
| Dividend Per Share | $2.08 |
| Dividend Yield | 0.95% |
| Dividend Growth (YoY) | 10.64% |
| Years of Dividend Growth | 13 |
| Payout Ratio | 54.59% |
| Buyback Yield | 0.47% |
| Shareholder Yield | 1.43% |
| Earnings Yield | 1.75% |
| FCF Yield | 2.87% |
Analyst Forecast
The average price target for STERIS is $244.33, which is 11.90% higher than the current price. The consensus rating is "Buy".
| Price Target | $244.33 |
| Price Target Difference | 11.90% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 7.13% |
| EPS Growth Forecast (5Y) | 26.87% |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 3.87 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.87 |
| Piotroski F-Score | 7 |